February 02, 2015

Cosmo Technologies Limited et al v. Par Pharmaceutical Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 26, 2016

    Valeant, Par End Patent Suit Over Colitis Treatment

    Par Pharmaceuticals Inc. reached a settlement Monday in a patent infringement suit brought by Valeant Pharmaceuticals International and Cosmo Pharmaceuticals Ltd. in Delaware federal court over Par’s attempt to make a generic of the colitis treatment Uceris.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS